Artera

Artera, founded in 2021, is a precision medicine company that develops multimodal artificial intelligence (MMAI) tests to personalize cancer therapy. Their flagship product, the ArteraAI Prostate Test, analyzes both digital pathology images and clinical data to predict patient outcomes and determine the potential benefit of specific treatments, such as hormone therapy, for individuals with localized prostate cancer. This approach enables clinicians to tailor treatment plans to each patient’s unique profile, aiming to improve outcomes and reduce unnecessary side effects.

The company has attracted significant investment from a diverse group of investors. In March 2023, Artera announced a $90 million funding round with participation from Coatue, Johnson & Johnson Innovation, Koch Disruptive Technologies, Walden Catalyst Ventures, TIME Ventures, Breyer Capital, and The Factory, as well as angel investors including Marc Benioff. Subsequently, in February 2024, Artera secured an additional $20 million in funding from investors such as Prosperity7 Ventures, EDBI, Walden Catalyst Ventures, Wilson Sonsini Goodrich & Rosati, and Trium Ventures.

Artera’s uniqueness lies in its MMAI platform, which integrates diverse data modalities to create predictive and prognostic cancer tests. By combining histopathological and clinical data, the platform provides comprehensive insights into disease progression and treatment efficacy. This methodology addresses the challenge of personalizing cancer treatment, moving beyond traditional one-size-fits-all approaches to more targeted therapies.

In the artificial intelligence landscape, Artera operates within the category of AI-driven precision medicine. Their technology applies machine learning algorithms to multimodal data, facilitating the development of predictive biomarkers and personalized treatment strategies in oncology.

For more information, please visit artera.ai.

To claim this startup page, go to the Contact page and send us a message with your full name, startup name, job title, and startup email address. We will review your request and get back to you. Once verified, you can update your startup information.